Gui Huang
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Advanced biosensing and bioanalysis techniques 2
- CRISPR and Genetic Engineering 2
- Glycosylation and Glycoproteins Research 1
-
- Nanoplatforms for cancer theranostics 5
- Co-authors
- Na Zhang (1 shared paper)Wen Xu (1 shared paper)Xuenong Zhang (7 shared papers)Wenjun Wan (4 shared papers)Jiang Wu (3 shared papers)Yan Zhang (1 shared paper)Qianglin Zeng (3 shared papers)Yamei Zhang (2 shared papers)
- Journals
- International Journal of Pharmaceutics (3 papers)Cancer Management and Research (2 papers)Acta Biomaterialia (2 papers)Advanced Healthcare Materials (1 paper)Journal of Drug Delivery Science and Technology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Gui Huang
18 papers receiving 515 citations
Peers
Comparison fields: 5 of 88
- Pharmaceutical Science 95
- Cancer Research 123
- Biomaterials 84
- Molecular Medicine 22
- Molecular Biology 285
Countries citing papers authored by Gui Huang
This map shows the geographic impact of Gui Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gui Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gui Huang more than expected).
Fields of papers citing papers by Gui Huang
This network shows the impact of papers produced by Gui Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gui Huang. The network helps show where Gui Huang may publish in the future.
Co-authors
The 25 scholars most cited alongside Gui Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 145 | |
| 2 | 2018 | 78 | |
| 3 | 2016 | 45 | |
| 4 | 2021 | 42 | |
| 5 | 2021 | 42 | |
| 6 | 2022 | 34 | |
| 7 | 2023 | 31 | |
| 8 | 2019 | 31 | |
| 9 | 2020 | 23 | |
| 10 | 2019 | 12 | |
| 11 | 2023 | 11 | |
| 12 | 2018 | 8 | |
| 13 | 2019 | 7 | |
| 14 | 2016 | 5 | |
| 15 | 2023 | 5 | |
| 16 | 2024 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2018 | 2 | |
| 19 | 2019 | 0 | |
| 20 | 2025 | 0 |
About Gui Huang
Gui Huang is a scholar working on Molecular Biology, Biomedical Engineering, Oncology, Cancer Research and Biomaterials, having authored 20 papers that have together received 528 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (3 papers), Cancer-related molecular mechanisms research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), CRISPR and Genetic Engineering (2 papers), Glioma Diagnosis and Treatment (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Pharmaceutical Science (95 citations), Cancer Research (123 citations), Biomaterials (84 citations), Molecular Medicine (22 citations) and Molecular Biology (285 citations). Gui Huang has collaborated with scholars based in China and United States. Frequent co-authors include Na Zhang, Wen Xu, Xuenong Zhang, Wenjun Wan, Jiang Wu, Yan Zhang, Qianglin Zeng, Yamei Zhang, Yu Wang and Hui Li. Their work appears in journals such as International Journal of Pharmaceutics, Cancer Management and Research, Acta Biomaterialia, Advanced Healthcare Materials and Journal of Drug Delivery Science and Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.